trial

Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia

NCTId NCT00797927
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 30 (actual)
Sponsored by National Taiwan University Hospital
Primary completion 2009-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
30 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2007-01
Primary completion
2009-03
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Drugs
Quetiapine

Sponsors

National Taiwan University HospitalLead Sponsor
National Science and Technology Council, TaiwanCollaborator

Investigators

1
Tzung-Jeng Hwang, MD, MPH, PhDPrincipal Investigator

Sites

1 total
Taipei, Taiwan

Facts & assertions

4 sourced
Enrollment
30
Phase
PHASE4
Primary Completion Date
2009-03
Status
COMPLETED
relationships
The graph out of here
drug
Quetiapine
drug
lead_sponsor
National Taiwan University Hospital
company
collaborator
National Science and Technology Council, Taiwan
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Tzung-Jeng Hwang, MD, MPH, PhD
person